Trial intelligence / Profile preview

Divalproex Sodium ER for Cognition in Schizophrenia

NCT00306475Phase 4Completed

Sponsor
Northwestern University
Start
Mar 2006
Primary completion
Apr 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of divalproex sodium in schizophrenia, schizoaffective disorder, sponsored by Northwestern University. Started Mar 2006; status: completed.

02

Drugs

divalproex sodium
03

Conditions

schizophreniaschizoaffective disorder

Beyond the preview

Go deeper on NCT00306475.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00306475.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call